Not saying it's great/perfect, but here's more about the bill:
As noted in the article, the bill doesn't ban animal testing outright but animal testing isn't always the same as human response and there may be times when other alternatives would be better:
"Over the decades, however, science and data have shown that product animal testing does not always replicate the potential toxic responses in humans.
Upon the Senate passing the FDA Modernization Act 2.0, Paul said the U.S. Federal Food, Drug and Cosmetic Act was passed when the only testing methods available were animal trials or human trials. In modern day, statistics show that animal testing is a flawed system, with over 50% of drugs that pass animal trials failing in human clinical trials. Meanwhile, animal testing can be twice as expensive than non-animal alternatives."
"This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods."
Not saying it's great/perfect, but here's more about the bill:
As noted in the article, the bill doesn't ban animal testing outright but animal testing isn't always the same as human response and there may be times when other alternatives would be better:
"Over the decades, however, science and data have shown that product animal testing does not always replicate the potential toxic responses in humans.
Upon the Senate passing the FDA Modernization Act 2.0, Paul said the U.S. Federal Food, Drug and Cosmetic Act was passed when the only testing methods available were animal trials or human trials. In modern day, statistics show that animal testing is a flawed system, with over 50% of drugs that pass animal trials failing in human clinical trials. Meanwhile, animal testing can be twice as expensive than non-animal alternatives."
Per the Bill Summary at https://www.congress.gov/bill/117th-congress/senate-bill/2952 -
"This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods."